Crossmark

Adverse events associated with SARS-CoV-2 neutralizing monoclonal antibodies using the FDA adverse event reporting system database

Published Online: 2024-07-30

Published Print: 2024-10

Authors

Choi, Min Joung

Oh, Se-Hun

Song, Yun-Kyoung

Ki, Sung Hwan https://orcid.org/0000-0003-0761-3750
Funding

Funding for this research was provided by:

Chosun University (2022)
License Information

Text and Data Mining valid from 2024-07-30

Version of Record valid from 2024-07-30
More Information

Article History

Received: 28 March 2024

Revised: 20 June 2024

Accepted: 10 July 2024

First Online: 30 July 2024

Declarations

:

: Sung Hwan Ki was the Associate Editor of Toxicological Research while the manuscript of this article was submitted and peer-reviewed. Editorial Board Member status has no bearing on editorial consideration.

Document is current